Kabashima, Kenji

Janus kinase inhibitor delgocitinib suppresses pruritus and nerve elongation in an atopic dermatitis murine model

Yamamoto, Y., Otsuka, A., Nakashima, C., Ishida, Y., Honda, T., Egawa, G., Amano, W., Usui, K., Hamada, Y., Wada, M., et al. (2020) · Journal of Dermatological Science

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 26

ADAMTSL5 Is upregulated in melanoma tissues in patients with idiopathic psoriasis vulgaris induced by nivolumab

Nonomura, Y., Otsuka, A., Ohtsuka, M., Yamamoto, T., Dummer, R., & Kabashima, K. (2017) · Journal of the European Academy of Dermatology and Venereology

Cancer Immunotherapy and BiomarkersPsoriasis: Treatment and Pathogenesis

Cited by 19

HLA-A*26 is correlated with response to nivolumab in Japanese melanoma patients

Ishida, Y., Otsuka, A., Tanaka, H., Levesque, M. P., Dummer, R., & Kabashima, K. (2017) · Journal of Investigative Dermatology

Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management

Cited by 13

Upregulation of granzyme B and interferon‐γ mRNA in responding lesions by treatment with nivolumab for metastatic melanoma: a case report

Anegawa, H., Otsuka, A., Kaku, Y., Nonomura, Y., Fujisawa, A., Endo, Y., & Kabashima, K. (2016) · Journal of the European Academy of Dermatology and Venereology

Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management

Cited by 9

Refractory Seborrheic Dermatitis of the Head in a Patient with Malignant Lymphoma

Okada, K., Endo, Y., Fujisawa, A., Tanioka, M., Kabashima, K., & Miyachi, Y. (2014) · Case Reports in Dermatology

Nail Diseases and TreatmentsCutaneous lymphoproliferative disorders research

Cited by 8